Chitra Mani

696 total citations
17 papers, 560 citations indexed

About

Chitra Mani is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Chitra Mani has authored 17 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Genetics. Recurrent topics in Chitra Mani's work include Pharmacogenetics and Drug Metabolism (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Estrogen and related hormone effects (5 papers). Chitra Mani is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Estrogen and related hormone effects (5 papers). Chitra Mani collaborates with scholars based in United States and India. Chitra Mani's co-authors include David Kupfer, Ernest Hodgson, Harry V. Gelboin, R PEARCE, A. Parkinson, Robin E. Pearce, Andrew Parkinson, Kenneth W. Turteltaub, Mint Sirisawad and Sriram Balasubramanian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Chitra Mani

16 papers receiving 537 citations

Peers

Chitra Mani

PHARM

GENET

ONCOL

PHARM

Adrian Davies United Kingdom

Mary Jo Ricci United States

Isamu Terashima Japan

Indra Dwivedy India

David J. Porubek United States

Sarah Chouinard Canada

Hong Zuo China

Jean-Sébastien Carrier Canada

Stanley Venitt United Kingdom

Anja Rode United Kingdom

Adrian Davies United Kingdom

Chitra Mani

200 ×0.8

PHARM

280 ×1.2

GENET

201 ×0.9

90 ×0.6

ONCOL

76 ×0.9

PHARM

Citations per year, relative to Chitra Mani Chitra Mani (= 1×) peers Adrian Davies

Countries citing papers authored by Chitra Mani

Since Specialization

Citations

This map shows the geographic impact of Chitra Mani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chitra Mani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chitra Mani more than expected).

Fields of papers citing papers by Chitra Mani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chitra Mani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chitra Mani. The network helps show where Chitra Mani may publish in the future.

Co-authorship network of co-authors of Chitra Mani

This figure shows the co-authorship network connecting the top 25 collaborators of Chitra Mani. A scholar is included among the top collaborators of Chitra Mani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chitra Mani. Chitra Mani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Evens, Andrew M., Sriram Balasubramanian, Julie M. Vose, et al.. (2015). A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma. Clinical Cancer Research. 22(5). 1059–1066. 73 indexed citations

Mathew, Bijo, et al.. (2014). Isolation of chemical constituents from Spilanthes calva DC: Toxicity, anthelmintic efficacy and in silico studies. Biomedicine & Preventive Nutrition. 4(3). 417–423. 4 indexed citations

Choy, Edwin, Yael Flamand, Sriram Balasubramanian, et al.. (2014). Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma. Cancer. 121(8). 1223–1230. 53 indexed citations

Choy, Edwin, Sriram Balasubramanian, James E. Butrynski, et al.. (2013). Abstract LB-167: Phase I dose escalation study of abexinostat and doxorubicin in patients with metastatic sarcomas.. Cancer Research. 73(8_Supplement). LB–167. 1 indexed citations

Mani, Chitra, et al.. (2012). Identification and characterization using isoenzymes of glucose-6-phosphate dehydrogenase in Eclipta prostrata (L.) L., Mant. European Journal of Experimental Biology. 2(4). 1 indexed citations

Balasubramanian, Sriram, et al.. (2012). Abstract 1039: Histone deacetylase 8 (HDAC8) target identification and mechanism of action of HDAC8 isoform-specific inhibitors. Cancer Research. 72(8_Supplement). 1039–1039. 2 indexed citations

Evens, Andrew M., Weiyun Z. Ai, Sriram Balasubramanian, et al.. (2009). Phase I Analysis of the Safety and Pharmacodynamics of the Novel Broad Spectrum Histone Deacetylase Inhibitor (HDACi) PCI-24781 in Relapsed and Refractory Lymphoma.. Blood. 114(22). 2726–2726. 7 indexed citations

Undevia, Samir D., Linda Janisch, Richard L. Schilsky, et al.. (2008). Phase I study of the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of the histone deacetylase inhibitor (HDACi) PCI-24781. Journal of Clinical Oncology. 26(15_suppl). 14514–14514. 14 indexed citations

Mani, Chitra, et al.. (2005). Reductase‐mediated metabolism of motexafin gadolinium (Xcytrin®) in rat and human liver subcellular fractions and purified enzyme preparations. Journal of Pharmaceutical Sciences. 94(3). 559–570. 6 indexed citations

10.

Turteltaub, Kenneth W. & Chitra Mani. (2003). Benzene metabolism in rodents at doses relevant to human exposure from urban air.. PubMed. 1–26; discussion 27. 18 indexed citations

11.

Mani, Chitra, Stewart P.H.T. Freeman, David Nelson, John S. Vogel, & Kenneth W. Turteltaub. (1999). Species and Strain Comparisons in the Macromolecular Binding of Extremely Low Doses of [14C]Benzene in Rodents, Using Accelerator Mass Spectrometry. Toxicology and Applied Pharmacology. 159(2). 83–90. 14 indexed citations

12.

Mani, Chitra, Robin E. Pearce, Andrew Parkinson, & David Kupfer. (1994). Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. Carcinogenesis. 15(12). 2715–2720. 55 indexed citations

13.

Kupfer, David, et al.. (1994). Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.. PubMed. 54(12). 3140–4. 29 indexed citations

14.

Mani, Chitra, et al.. (1993). Reversible and time‐dependent inhibition of the hepatic cytochrome P450 steroidal hydroxylases by the proestrogenic pesticide methoxychlor in rat and human. Journal of Biochemical Toxicology. 8(4). 195–206. 13 indexed citations

15.

Mani, Chitra, Ernest Hodgson, & David Kupfer. (1993). Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.. Drug Metabolism and Disposition. 21(4). 657–661. 66 indexed citations

16.

Mani, Chitra, et al.. (1993). Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.. Drug Metabolism and Disposition. 21(4). 645–656. 105 indexed citations

17.

Mani, Chitra & David Kupfer. (1991). Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.. PubMed. 51(22). 6052–8. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact